IOVA Iovance Biotherapeutics, Inc.
Healthcare$4.11+11.08%ClosedMarket Cap: $1.47B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
2
Buy/Sell Ratio
0.50
Net Shares
-2,435
Shares Acquired
10,000
Shares Disposed
12,435
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed May 13 | Kirby Daniel Gordon | officer: Chief Commercial Officer | Sell | 10,000 | $0.00 | 149,381 |
| Wed May 13 | Kirby Daniel Gordon | officer: Chief Commercial Officer | Sell | 2,435 | $3.70 | 146,946 |
| Wed Mar 11 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | Sell | 235,000 | $0.00 | 235,000 |
| Wed Mar 11 | Roche Corleen M. | officer: Chief Financial Officer | Sell | 132,200 | $0.00 | 132,200 |
| Wed Mar 11 | Puri Raj K. | officer: Chief Regulatory Officer | Sell | 117,500 | $0.00 | 117,500 |
| Wed Mar 11 | Kirby Daniel Gordon | officer: Chief Commercial Officer | Sell | 132,200 | $0.00 | 132,200 |
| Wed Mar 11 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | Sell | 58,750 | $0.00 | 58,750 |
| Wed Mar 11 | BILINSKY IGOR | officer: Chief Operating Officer | Sell | 117,500 | $0.00 | 117,500 |
| Fri Mar 06 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | Sell | 62,493 | $0.00 | 556,293 |
| Fri Mar 06 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | Sell | 26,755 | $4.58 | 529,538 |
| Fri Mar 06 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | Sell | 31,246 | $0.00 | 148,477 |